172 related articles for article (PubMed ID: 37038822)
1. Supporting Huntington's Disease Families Through the Ups and Downs of Clinical Trials.
Andrew KM; Fox LM
J Huntingtons Dis; 2023; 12(1):71-76. PubMed ID: 37038822
[TBL] [Abstract][Full Text] [Related]
2. Survey of the Huntington's Disease Patient and Caregiver Community Reveals Most Impactful Symptoms and Treatment Needs.
Simpson JA; Lovecky D; Kogan J; Vetter LA; Yohrling GJ
J Huntingtons Dis; 2016 Dec; 5(4):395-403. PubMed ID: 27983566
[TBL] [Abstract][Full Text] [Related]
3. Attitudes of Potential Participants Towards Molecular Therapy Trials in Huntington's Disease.
Bardakjian TM; Naczi KF; Gonzalez-Alegre P
J Huntingtons Dis; 2019; 8(1):79-85. PubMed ID: 30689592
[TBL] [Abstract][Full Text] [Related]
4. Geographic Barriers Drive Disparities in Specialty Center Access for Older Adults with Huntington's Disease.
Pham Nguyen TP; Bravo L; Gonzalez-Alegre P; Willis AW
J Huntingtons Dis; 2022; 11(1):81-89. PubMed ID: 35253771
[TBL] [Abstract][Full Text] [Related]
5. From open to large-scale randomized cell transplantation trials in Huntington's disease: Lessons from the multicentric intracerebral grafting in Huntington's disease trial (MIG-HD) and previous pilot studies.
Bachoud-Lévi AC
Prog Brain Res; 2017; 230():227-261. PubMed ID: 28552231
[TBL] [Abstract][Full Text] [Related]
6. Positive Attitudes and Therapeutic Misconception Around Hypothetical Clinical Trial Participation in the Huntington's Disease Community.
Cotter K; Siskind CE; Sha SJ; Hanson-Kahn AK
J Huntingtons Dis; 2019; 8(4):421-430. PubMed ID: 31594242
[TBL] [Abstract][Full Text] [Related]
7. Addressing the Value of Multidisciplinary Clinical Care in Huntington's Disease: A Snapshot of a New Huntington's Disease Center.
Bardakjian TM; Klapper J; Carey A; Wood J; Pauly M; Gasper K; Lawler K; Tran B; Bell Y; Zwil A; Gonzalez-Alegre P
J Huntingtons Dis; 2019; 8(4):501-507. PubMed ID: 31381522
[TBL] [Abstract][Full Text] [Related]
8. Striving for a Realistic and Unapologetic View of Huntington's Disease.
Serbin KP
J Huntingtons Dis; 2022; 11(4):369-371. PubMed ID: 36502336
[TBL] [Abstract][Full Text] [Related]
9. Supporting physical activity engagement in people with Huntington's disease (ENGAGE-HD): study protocol for a randomized controlled feasibility trial.
Busse M; Quinn L; Dawes H; Jones C; Kelson M; Poile V; Trubey R; Townson J; Edwards RT; Rosser A; Hood K
Trials; 2014 Dec; 15():487. PubMed ID: 25494622
[TBL] [Abstract][Full Text] [Related]
10. Update on Huntington's disease: advances in care and emerging therapeutic options.
Zielonka D; Mielcarek M; Landwehrmeyer GB
Parkinsonism Relat Disord; 2015 Mar; 21(3):169-78. PubMed ID: 25572500
[TBL] [Abstract][Full Text] [Related]
11. Supporting Trial Participation in People with the Huntington's Gene: A Patient-Centered, Theory-Guided Survey of Barriers and Enablers.
Carroll K; Hudek N; Bénard A; Presseau J; Richards DP; Susan M; Fergusson DA; Graham ID; Mestre TA; Brehaut JC
J Huntingtons Dis; 2022; 11(4):421-434. PubMed ID: 36155526
[TBL] [Abstract][Full Text] [Related]
12. Speech and language difficulties in Huntington's disease: A qualitative study of patients' and professional caregivers' experiences.
Grimstvedt TN; Miller JU; van Walsem MR; Feragen KJB
Int J Lang Commun Disord; 2021 Mar; 56(2):330-345. PubMed ID: 33577706
[TBL] [Abstract][Full Text] [Related]
13. Huntington's Disease: New Frontiers in Therapeutics.
Pan L; Feigin A
Curr Neurol Neurosci Rep; 2021 Feb; 21(3):10. PubMed ID: 33586075
[TBL] [Abstract][Full Text] [Related]
14. Clinical Features of Huntington's Disease.
Ghosh R; Tabrizi SJ
Adv Exp Med Biol; 2018; 1049():1-28. PubMed ID: 29427096
[TBL] [Abstract][Full Text] [Related]
15. New Avenues for the Treatment of Huntington's Disease.
Kim A; Lalonde K; Truesdell A; Gomes Welter P; Brocardo PS; Rosenstock TR; Gil-Mohapel J
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445070
[TBL] [Abstract][Full Text] [Related]
16. Targets for future clinical trials in Huntington's disease: what's in the pipeline?
Wild EJ; Tabrizi SJ
Mov Disord; 2014 Sep; 29(11):1434-45. PubMed ID: 25155142
[TBL] [Abstract][Full Text] [Related]
17. Huntington's Disease Community Perspectives on Desired Characteristics of Disease Modifying Therapies.
Gornick MC; Ryan KA; Dayalu P; Carlozzi NE; Albin RL; Zahuranec DB
Tremor Other Hyperkinet Mov (N Y); 2021 Jan; 11():3. PubMed ID: 33569244
[TBL] [Abstract][Full Text] [Related]
18. Genetics of Huntington disease.
Nance MA
Handb Clin Neurol; 2017; 144():3-14. PubMed ID: 28947123
[TBL] [Abstract][Full Text] [Related]
19. Quality of Care for Huntington's Disease in the United States: Findings from a National Survey of Patients and Caregivers.
Anderson KE; Griffin J; Kinel A; Shaikh AR; Olofintuyi T; Ramirez S; Steinman J; Yohrling GJ; Kinel S;
J Huntingtons Dis; 2019; 8(4):509-519. PubMed ID: 31594241
[TBL] [Abstract][Full Text] [Related]
20. Huntington's disease: diagnosis and management.
Stoker TB; Mason SL; Greenland JC; Holden ST; Santini H; Barker RA
Pract Neurol; 2022 Feb; 22(1):32-41. PubMed ID: 34413240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
